Portfolio
FROM LIFE SCIENCES TO PHARMACEUTICALS, TECHNOLOGY, REAL ESTATE AND BEYOND
At Fabisman Investment, we invest in innovative young companies and funds that drive medical advancements, enhance general well-being, and develop premium real estate. Our strategy includes direct primary and secondary transactions aligned with these objectives. Additionally, we seek opportunities in theme-based funds and attractive real estate investments.
Take a look at our portfolio of funds…
LIFE SCIENCES PORTFOLIO
Novimmune SA
One of our key biotech investments which we exited in 2019. Novimmune is a privately held Swiss pharmaceutical development company focusing on monoclonal antibody therapies for treatment of immune-related diseases.
We have now exited this investment.
Release Therapeutics SA
A Swiss clinical-stage biotech company developing novel anti-cancer vaccines, and cell-based immunotherapy for the treatment of cancers. Also, Empowering Lives with Unique CNS directed Therapeutics.
Sectoral Asset Management
New Emerging Medical Opportunities (NEMO) venture capital funds for late-stage Biotech and MedTech companies across North America and Europe.
CurvaFix
The CurvaFix IM Implant is the only intramedullary implantable device capable of following the natural bone curvature within the pelvis. It is flexible during implantation to reach challenging pelvic fractures, and is locked in a rigid state once in place.
EDGe Surgical
EDGe Surgical is innovating state-of- the-art digital technology to set a new standard in orthopedic surgery instrumentation that will bring better outcomes to patients and reduce healthcare system costs.
Neuros Medical
Neuros Medical is a bioelectric medical technology company who have developed the Altius System for the critical purpose of alleviating chronic post-amputation pain and restoring quality of life.
Cagent Vascular
Cagent Vascular is pioneering serration technology dedicated to improving the treatment of cardiovascular disease.
REAL ESTATE PORTFOLIO
Elite Residence
Elite Residence is a residential tower located in one of the most envied neighborhoods in Dubai. Amongst the world’s tallest buildings, Elite Residence reaches high above the exclusive Dubai Marina. The imposing 91-storey tower makes a statement of luxury living in a city that has it all.
Berlin Landbanking Fund, Deutsche Landentwicklung
DLE Land Development GmbH is Europe’s market leader in future-oriented neighborhood development in Germany. Redemption of their fund for land development in Berlin, started in 2021.
https://www.dle.ag/our-business-lines/dle-land-development-gmbh
DLE Group AG
DLE Group AG is a leading real estate asset management platform in Europe that serves institutional clients and professional investors worldwide, offering innovative investment products along the real estate value chain.
CONNECT WITH US
We are an investment house eager to fund start-up biotech companies during their development phase or pre-IPO stage. We also consider private acquisitions as a secondary investor.
Please contact us to find out more.